Reversal of threatening blindness after initiation of eculizumab in Purtscher-like retinopathy secondary to atypical hemolytic uremic syndrome. [electronic resource]
Producer: 20180510Description: 399-407 p. digitalISSN:- 1573-2630
- Antibodies, Monoclonal, Humanized -- administration & dosage
- Atypical Hemolytic Uremic Syndrome -- complications
- Blindness -- drug therapy
- Dose-Response Relationship, Drug
- Female
- Fluorescein Angiography
- Follow-Up Studies
- Fundus Oculi
- Humans
- Recovery of Function
- Retinal Diseases -- complications
- Tomography, Optical Coherence -- methods
- Visual Acuity
- Young Adult
No physical items for this record
Publication Type: Case Reports; Journal Article
There are no comments on this title.
Log in to your account to post a comment.